S. 2398

119th Congress

Introduced

Kay Hagan Tick Reauthorization Act

Sponsored byRepublican:Sen. Collins, Susan M. [R-ME]ME· Introduced 23 July 2025
Open on Congress.gov

23

Cosponsors

17

Actions

0

Amendments

1

Committees

—

Since introduced

Step 0 of 0
Latest action

Motion to reconsider laid on the table Agreed to without objection.

15 September 2026·5 days ago

Summary

Passed Senate · Updated 9 September 2026

Kay Hagan Tick Reauthorization Act

This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.

Timeline

17 actions

  1. DEBATE - The House proceeded with forty minutes of debate on S. 2398.

    15 September 2026 · Floor

  2. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.

    15 September 2026 · Floor

  3. Considered under suspension of the rules.

    15 September 2026 · Floor

  4. Motion to reconsider laid on the table Agreed to without objection.

    15 September 2026 · Floor

  5. On motion to suspend the rules and pass the bill Agreed to by voice vote.

    15 September 2026 · Floor

  6. Mr. Guthrie moved to suspend the rules and pass the bill.

    15 September 2026 · Floor

  7. Held at the desk.

    10 August 2026 · Floor

  8. Received in the House.

    10 August 2026 · Floor

  9. Received in the House.

    10 August 2026 · Floor

  10. Held at the desk.

    10 August 2026 · Floor

  11. Message on Senate action sent to the House.

    10 August 2026 · Floor

  12. Message on Senate action sent to the House.

    10 August 2026 · Floor

  13. Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  14. Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  15. Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  16. Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  17. Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  18. Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)

    6 August 2026 · Floor

  19. Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

    8 September 2025 · Committee

  20. Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

    8 September 2025 · Committee

Sponsorship

23 cosponsors

Sponsor

Republican:Sen. Collins, Susan M. [R-ME]ME

Cosponsors

  • Democrat1565%
  • Republican730%
  • Independent14%

Classification

Policy area

Health

Legislative subjects

Health programs administration and fundingInfectious and parasitic diseasesInsects

Committees

1

  • Health, Education, Labor, and Pensions Committee

    Senate · Standing

    • Referred To23 Jul 2025
    • Markup By30 Jul 2025
    • Reported By8 Sept 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 5 on 23 July 2025 to 23 on 19 May 2026.

Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.